Marc is a senior CMC consultant with a broad and varied experience, covering projects from preclinical to commercial, from small molecules to biologics and ATMP, in various dosage forms. He mostly supports startup biotech companies as Head of CMC, developing strategies, identifying and engaging with external partners and CDMOs, executing projects to ensure drug supply and regulatory approval.

Marc has worked in the pharmaceutical industry for more than 20 years and started his own consultancy in 2018. Previously, he was VP R&D at Fresenius Kabi and Head of the Innovation & Development Centre in Uppsala, Sweden, and Director of Process Development at Baxter Healthcare in Brussels, Belgium. Marc obtained his PhD in organic chemistry at the Max Planck Institute for Coal Research.

Presentation Title: Development of the First Sumatriptan Buccal Film: From Concept to Market Approval

View company profile